Lack of patient adherence and compliance is a major concern for the pharmaceutical companies as it increases the potential need for a higher degree of treatment for patients. This is due to the fact that poor or lack of adherence results in poor health of the patient and in turn results in increased healthcare costs for the healthcare system. It is estimated that about 40% of revenue loss for major pharmaceutical companies is attributed to patient non-adherence and non-compliance. Pharmaceutical companies are investing significantly in order to develop effective solutions to address the growing problem of patient non-adherence and non-compliance.
There are several factors that influence the adherence of patients. Some of these include patient related factors, therapy related factors, disease related factors, cost related factors, factors related to the healthcare system itself, and other socio-economic factors. Patient related factors include the attitude of the patient, the awareness level or lack of it, and misconceptions and perceptions about the disease and its treatment. Cost-related factors are one of the main factors as affordability is a major problem for those without health insurance and also in developing countries.
The patient adherence and compliance market has been segmented on the basis of type as
In-house adherence support and Outsourced adherence support.
The patient adherence and compliance market has been segmented on the basis of technique used as
Clinical innovation, Patient counseling and education, Software Apps and others
North America accounts for the largest share of the overall patient adherence and compliance market. This can be attributed to the developed healthcare system, increasing geriatric population coupled with the increasing cases of chronic illnesses that are prevalent in the region. The market has been segmented based on the following geographies
North America, South America, APAC, Europe, Middle East and Africa
Following are just a few of the companies that are operating in the Patient Adherence and Compliance Market
S3 Group, Adherence Solutions LLC, Qualcomm Inc., Koninklijke Philips N.V. and Adheretech, Inc.
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
2. Executive Summary
3. Patient Adherence and Compliance– Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Top 5 Financials Analysis
4. Patient Adherence and Compliance– Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Patient Adherence and Compliance Market
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. Patient Adherence and Compliance Market– Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. Patient Adherence and Compliance Market– By Type:
7. Patient Adherence and Compliance Market– By Technique:
7.1. Clinical innovation
7.2. Patient counseling and education
7.3. Software Apps
8. Patient Adherence and Compliance Market– By Geography:
8.2. Global Study
8.3.1. North America
9. Market Entropy
9.1. New Product Launches
9.2. M&As, Collaborations, JVs and Partnerships
10. Company Profiles
10.1. S3 Group
10.2. Adherence Solutions LLC
10.4. ProteUs Digital Health Inc.
10.5. HCL Technologies
10.8. Smrxt, Inc.
10.9. Qualcomm Inc.
10.10. Koninklijke Philips N.V.
10.11. Adheretech, Inc.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11.3. Research Methodology
11.5. Compilation of Expert Insights